As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Stanford, who was not involved in this research, is an obesity medicine physician scientist, educator and policy maker at Massachusetts General Hospital and Harvard Medical School, both in Boston
Reviewed by Dietitian Kelly Plowe, M.S., RD Key Points GLP-1s curb appetite and slow digestion, supporting weight loss but complicating nutrient needs
Semaglutide dosing chart for 2mg/mL concentration The 2mg/mL concentration is one of the most common formulations from compounding pharmacies
Now, the difficulty with low B12 levels are that yes, they are more likely to be associated with intestinal problems, but we don't always get overt diarrhea or vomiting with those diseases
There have been multiple randomised controlled trials and systematic reviews that have explored this
So, much like tanning beds, this is one you should probably avoid if you want to look after your skin, with some sunlight and Factor 50, or even a few carrots, perhaps the best way to earn a more natural tan